Transapical Transcatheter Mitral Valve-In-Valve Implantation Using an Edwards SAPIEN 3 Valve

2018 ◽  
Vol 27 (3) ◽  
pp. e23-e24
Author(s):  
Javier Gualis ◽  
Rodrigo Estévez-Loureiro ◽  
David Alonso ◽  
Jose Manuel Martínez-Comendador ◽  
Elio Martín ◽  
...  
2017 ◽  
Vol 26 (4) ◽  
pp. e19-e21 ◽  
Author(s):  
Cheng He ◽  
Gregory Scalia ◽  
Darren L. Walters ◽  
Andrew Clarke

Author(s):  
Riccardo Cocchieri ◽  
Ezra Y. Koh ◽  
Bas A. De Mol

We report a case of transapical mitral valve-in-valve implantation for a deteriorated bioprosthesis using the SAPIEN 3. Our patient, a 79-year-old man, with a history of mitral valve replacement 10 years before, presented with acute dyspnea due to mitral valve dysfunction. He was successfully treated with transapical implantation and had an uneventful recovery. Our case demonstrates the feasibility of using SAPIEN 3 in treating degenerated bioprosthetic mitral valves.


2016 ◽  
Vol 31 (9) ◽  
pp. 575-577 ◽  
Author(s):  
Javier Gualis ◽  
Rodrigo Estévez-Loureiro ◽  
David Alonso ◽  
Jose Manuel Martínez-Comendador ◽  
Elio Martín ◽  
...  

Author(s):  
Anupama Shivaraju ◽  
Jonathan Michel ◽  
Antonio H. Frangieh ◽  
Ilka Ott ◽  
Christian Thilo ◽  
...  

2020 ◽  
Vol 7 (12) ◽  
pp. 201838
Author(s):  
Romina Plitman Mayo ◽  
Halit Yaakobovich ◽  
Ariel Finkelstein ◽  
Shawn C. Shadden ◽  
Gil Marom

Leaflet thrombosis has been suggested as the reason for the reduced leaflet motion in cases of hypoattenuated leaflet thickening of bioprosthetic aortic valves. This work aimed to estimate the risk of leaflet thrombosis in two post-valve-in-valve (ViV) configurations, using five different numerical approaches. Realistic ViV configurations were calculated by modelling the deployments of the latest version of transcatheter aortic valve devices (Medtronic Evolut PRO, Edwards SAPIEN 3) in the surgical Sorin Mitroflow. Computational fluid dynamics simulations of blood flow followed the dry models. Lagrangian and Eulerian measures of near-wall stagnation were implemented by particle and concentration tracking, respectively, to estimate the thrombogenicity and to predict the risk locations. Most of the numerical approaches indicate a higher leaflet thrombosis risk in the Edwards SAPIEN 3 device because of its intra-annular implantation. The Eulerian approaches estimated high-risk locations in agreement with the wall sheer stress (WSS) separation points. On the other hand, the Lagrangian approaches predicted high-risk locations at the proximal regions of the leaflets matching the low WSS magnitude regions of both transcatheter aortic valve implantation models and reported clinical and experimental data. The proposed methods can help optimizing future designs of transcatheter aortic valves with minimal thrombotic risks.


Author(s):  
Gry Dahle ◽  
Kjell-Arne Rein ◽  
Anders L. Jönsson

A 53-year-old woman, previously treated with irradiation and chemotherapy for Hodgkin lymphoma, was referred for redovalve surgery. She had had a pacemaker implantation and undergone coronary bypass surgery, mitral valve repair with a Carpentier-Edwards 28-mm Physio-annuloplasty ring, as well as a mechanical tricuspid valve replacement and a transfemoral CoreValve 26-mm implantation. She had cardiac cachexia, pleura effusion, and a failed mitral valve repair with stenosis. She was judged inoperable for open surgery but suitable for a transapical valve-in-valve implantation on partial femorofemoral bypass. A 26-mm Edwards SAPIEN XT aortic valve inversely mounted on the Ascendra + delivery catheter was balloon expanded into the Physio ring. During expansion, the introducer sheath remained too deep into the left ventricle and rotated the SAPIEN valve upward to the left atrium, creating the onset of a new mitral regurgitation and retaining the stenosis. Another Edwards SAPIEN XT 26-mm valve was then positioned into the first valve in a “valve-in-valve-in-ring” tandem configuration. Both valves were supported by the Physio ring. The stenosis and the regurgitation were thereafter eliminated.


Author(s):  
Nils Perrin ◽  
Hajo Muller ◽  
Stephane Noble

We present hereby the case of a 75-year-old woman with a degenerated mitral bioprosthesis and severely reduced left ventricular ejection fraction who underwent a successful trans-septal mitral valve-in-valve (TMViV) replacement using a 29mm Edwards Sapien S3 transcatheter heart valve. We also performed a literature review.


Sign in / Sign up

Export Citation Format

Share Document